Mabwell (shanghai) Bioscience Co., Ltd.

This is the first study in US patients testing an experimental drug called 7MW4911 for advanced gastrointestinal cancers that have stopped responding to standard treatments. The research aims to find the safest and most effective dose while checking if the drug helps shrink tumor…

This study is testing whether a combination of two drugs, 9MW2821 and toripalimab, can help shrink or eliminate tumors in patients with non-metastatic bladder cancer before they have surgery. The goal is to see if this treatment makes surgery more effective and helps prevent the …

This study is testing a new combination of two experimental drugs, 7MW3711 and JS207, for people with advanced solid tumors that have progressed after standard treatments. The main goals are to find the safest and most effective doses and to see if the combination can help contro…

This is the first study testing a new drug called 7MW4911 in people with advanced solid tumors that have stopped responding to other treatments. The main goals are to find the safest and most effective dose and to see if the drug shows early signs of helping shrink tumors. Resear…

This early-stage study is testing a new drug called bulumtatug fuvedotin for people with advanced triple-negative breast cancer that has returned or spread. The trial is for patients who have already tried other targeted treatments called antibody-drug conjugates. Researchers wan…

This study is testing an investigational medicine called 9MW1911 to see if it can help people with COPD. The main goal is to see if it reduces the number of serious breathing flare-ups over one year. About 360 participants will be randomly assigned to receive either the study med…